Dummy data
X
WE partner and build valuable, enduring, socially responsible businesses that generate
immense wealth for stake
holders

We are universally admired
and trusted managers of
intellectual and financial capital
X
PRUDENTLY invest in or buy and build world class businesses

BE thought leaders

FACILITATE exchange of knowledge and ideas and build a vibrant community of businesses and stakeholders

CREATE an exciting and
challenging environment for
a highly motivated and
empowered team
X
LOGIN
USERNAME
PASSWORD
    HELP | ENTER
HOME
Date of investment: May 2003

Founded by Kiran Mazumdar, Biocon was a pioneering enterprise in the Indian Biotech Industry. Biocon was in the business of bio-generics, specialty enzymes and contract research when IVFA decided to invest in it. It was the largest contract research organisation (CRO) in India and it was known for very good manufacturing and human resource practices.

Biocon launched its IPO in March 2004, which was oversubscribed 33 times and listed with a market capitalization of US$ 1 Billion. IVFA divested its stake in Biocon upon listing.

  • IVFA investment rationale >
    • Leading bio-generics Company in India; sunrise sector
    • Significant strength in fermentation technologies with large number of patents
    • Opportunity to capitalise on the trend of off-shoring
    • Substantial stability of revenues and profits

“IVFA has been an astute investor and an understanding partner with whom we have shared mutual trust and respect. As investors, they have been open and fair and we will always value them as "preferred partners." Ms Kiran Mazumdar - Founder Chairman, Biocon India Limited.

Detailed information on the Company is available at www.biocon.com